William Huyett, Chief Financial Officer at Cyclerion Therapeutics, Inc. (CYCN), sold 3,559 shares at $5.12 ($18K) on 2020-02-21, disclosed to the SEC on 2020-02-25.
Scheduled sale ($18k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CYCN | SELL | 2019-11-12 | $8K | — | Filing → |